These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 15947797

  • 21. The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec.
    Tournier M, Moride Y, Lesk M, Ducruet T, Rochon S.
    Can J Clin Pharmacol; 2008; 15(1):e22-35. PubMed ID: 18579928
    [Abstract] [Full Text] [Related]

  • 22. Economic cost of age-related macular degeneration: a review of recent research.
    Ke KM, Chakravarthy U, O'Neill C.
    Drugs Aging; 2006; 23(3):217-25. PubMed ID: 16608377
    [Abstract] [Full Text] [Related]

  • 23. New treatments for age-related macular degeneration.
    Mittra RA.
    Minn Med; 2003 Apr; 86(4):40-6. PubMed ID: 12797657
    [Abstract] [Full Text] [Related]

  • 24. Eye Conditions in Older Adults: Age-Related Macular Degeneration.
    Iroku-Malize T, Kirsch S.
    FP Essent; 2016 Jun; 445():24-8. PubMed ID: 27348529
    [Abstract] [Full Text] [Related]

  • 25. A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration.
    Brown MM, Brown GC, Brown HC, Peet J.
    Ophthalmology; 2008 Jun; 115(6):1039-1045.e5. PubMed ID: 17976724
    [Abstract] [Full Text] [Related]

  • 26. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller JA, Handa JT, Nguyen QD, Sung JU.
    Hum Gene Ther; 2001 Nov 01; 12(16):2029-32. PubMed ID: 11727737
    [Abstract] [Full Text] [Related]

  • 27. [New insights into the underestimated impairment of quality of life in age-related macular degeneration - a review of the literature].
    Meyer-Ruesenberg B, Richard G.
    Klin Monbl Augenheilkd; 2010 Aug 01; 227(8):646-52. PubMed ID: 20449793
    [Abstract] [Full Text] [Related]

  • 28. Measurement of the economic impact of visual impairment from age-related macular degeneration in Australia.
    Hopley C, Carter R, Mitchell P.
    Clin Exp Ophthalmol; 2003 Dec 01; 31(6):522-9. PubMed ID: 14641161
    [Abstract] [Full Text] [Related]

  • 29. Age-Related Macular Degeneration.
    Mehta S.
    Prim Care; 2015 Sep 01; 42(3):377-91. PubMed ID: 26319344
    [Abstract] [Full Text] [Related]

  • 30. Age-related macular degeneration in Onitsha, Nigeria.
    Nwosu SN.
    Niger J Clin Pract; 2011 Sep 01; 14(3):327-31. PubMed ID: 22037079
    [Abstract] [Full Text] [Related]

  • 31. Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration.
    Schmier JK, Halpern MT, Covert D, Delgado J, Sharma S.
    Retina; 2006 Sep 01; 26(9):1056-62. PubMed ID: 17151494
    [Abstract] [Full Text] [Related]

  • 32. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.
    Alexander SL, Linde-Zwirble WT, Werther W, Depperschmidt EE, Wilson LJ, Palanki R, Saroj N, Butterworth SL, Ianchulev T.
    Ophthalmology; 2007 Dec 01; 114(12):2174-8. PubMed ID: 18054636
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL, Roach JM.
    Consult Pharm; 2013 Nov 01; 28(11):723-37. PubMed ID: 24217192
    [Abstract] [Full Text] [Related]

  • 36. A study on plasma homocysteine level in age-related macular degeneration.
    Ghosh S, Saha M, Das D.
    Nepal J Ophthalmol; 2013 Nov 01; 5(2):195-200. PubMed ID: 24172554
    [Abstract] [Full Text] [Related]

  • 37. [Age related macular degeneration. A widespread disease].
    la Cour M, Nielsen NV, Larsen M, Haamann PH, Vinding T.
    Ugeskr Laeger; 2001 Nov 12; 163(46):6396-400. PubMed ID: 11816915
    [Abstract] [Full Text] [Related]

  • 38. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
    Tan JS, Mitchell P, Smith W, Wang JJ.
    Ophthalmology; 2007 Jun 12; 114(6):1143-50. PubMed ID: 17275090
    [Abstract] [Full Text] [Related]

  • 39. New treatments for age-related macular degeneration.
    Mittra RA, Ramsay RC.
    Minn Med; 2009 Jun 12; 92(6):41-4. PubMed ID: 19653472
    [Abstract] [Full Text] [Related]

  • 40. Age-related macular degeneration: treating the whole patient.
    Tasman W, Rovner B.
    Can J Ophthalmol; 2005 Jun 12; 40(3):389-91. PubMed ID: 15947809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.